terican

Last verified · v1.0

Calculator · health

Ciwa Ar (Clinical Institute Withdrawal Assessment For Alcohol, Revised) Calculator

Calculate CIWA-Ar scores to assess alcohol withdrawal severity across 10 domains, from nausea and tremor to hallucinations and orientation.

FreeInstantNo signupOpen source

Inputs

CIWA-Ar Total Score

—

Explain my result

0/3 free

Get a plain-English breakdown of your result with practical next steps.

CIWA-Ar Total Score—points

The formula

How the
result is
computed.

What Is the CIWA-Ar Score?

The Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar) is a validated 10-item clinical scale used to quantify the severity of alcohol withdrawal syndrome (AWS). Developed by Sullivan et al. and subsequently refined for routine bedside use, the CIWA-Ar enables clinicians to objectively measure withdrawal symptoms, guide pharmacological treatment decisions, and monitor patient progress at serial time points. The scale is endorsed by the U.S. Department of Veterans Affairs PAWS Program and is supported by peer-reviewed evidence published in PubMed Central. The CIWA-Ar represents a significant advancement in alcohol withdrawal assessment by providing a standardized, reproducible method that minimizes clinician-to-clinician variability and ensures consistent evaluation across diverse care settings.

The CIWA-Ar Formula

The total CIWA-Ar score is the arithmetic sum of nine symptom subscores — each rated on a 0 to 7 anchored scale — plus one orientation subscore rated 0 to 4:

CIWA-Ar = S1 + S2 + S3 + S4 + S5 + S6 + S7 + S8 + S9 + O

The maximum possible score is 67 points (9 subscores x 7 + orientation maximum of 4). Each subscore is obtained by direct clinician observation or structured patient interview and reflects a distinct physiological or neurological withdrawal domain. The scoring methodology employs anchored Likert scales, meaning each numerical value corresponds to a specific and concrete clinical descriptor rather than an abstract gradient. This anchoring approach ensures that different clinicians assessing the same patient will arrive at comparable scores, thereby enhancing the reliability and validity of serial assessments used to guide treatment decisions.

Clinical Validation and Standardization

The CIWA-Ar has undergone rigorous psychometric evaluation to establish its reliability, validity, and clinical utility. The scale demonstrates excellent internal consistency and inter-rater reliability, meaning that different trained clinicians assessing the same patient typically arrive at comparable scores. The anchored scoring system — where each numerical value corresponds to specific behavioral or physiological descriptors — is essential to this consistency. This standardized approach reduces subjective interpretation and enables meaningful serial comparisons within individual patients and across different clinical populations and care settings.

The 10 Assessment Domains

  • Nausea and Vomiting (0–7): Ranges from no symptoms (0) to constant nausea with frequent dry heaves and active vomiting (7).
  • Tremor (0–7): Assessed with arms extended and fingers spread; ranges from no tremor (0) to severe tremor visible even without arm extension (7).
  • Paroxysmal Sweats (0–7): Ranges from no visible perspiration (0) to drenching diaphoresis soaking clothing (7).
  • Anxiety (0–7): Ranges from calm and at ease (0) to acute panic states resembling severe delirium or acute psychosis (7).
  • Agitation (0–7): Ranges from normal activity (0) to pacing back and forth or constant thrashing (7).
  • Tactile Disturbances (0–7): Ranges from none (0) through mild itching, pins and needles, or numbness to continuous tactile hallucinations (7).
  • Auditory Disturbances (0–7): Ranges from absent (0) through mild sound sensitivity to continuous auditory hallucinations (7).
  • Visual Disturbances (0–7): Ranges from absent (0) through mild light sensitivity to continuous visual hallucinations (7).
  • Headache / Fullness in Head (0–7): Dizziness is explicitly excluded from this domain; ranges from not present (0) to extremely severe (7).
  • Orientation and Clouding of Sensorium (0–4): Ranges from fully oriented with intact serial addition ability (0) to complete disorientation for place and/or person (4). This is the only domain capped at 4.

Score Interpretation and Clinical Thresholds

  • Score 0–8 — Minimal or Absent Withdrawal: Symptom-triggered pharmacotherapy or close observation only; reassess every 1–2 hours.
  • Score 9–14 — Mild-to-Moderate Withdrawal: Pharmacological intervention, typically benzodiazepines, should be considered to prevent clinical escalation.
  • Score 15–19 — Moderate-to-Severe Withdrawal: Active medication management is required; monitor closely for rapid deterioration.
  • Score 20 or above — Severe Withdrawal: High risk for generalized tonic-clonic seizures and delirium tremens; intensive unit monitoring and aggressive pharmacotherapy are essential.

Worked Clinical Example

A 45-year-old patient is admitted 72 hours after stopping heavy daily alcohol use. The clinician records: Nausea/Vomiting = 4, Tremor = 4, Paroxysmal Sweats = 3, Anxiety = 4, Agitation = 2, Tactile Disturbances = 1, Auditory Disturbances = 2, Visual Disturbances = 1, Headache = 3, Orientation = 1. Total CIWA-Ar = 4+4+3+4+2+1+2+1+3+1 = 25. This score falls in the severe category (above 20), indicating high risk for seizure or delirium tremens and the need for immediate IV benzodiazepine therapy and intensive monitoring.

Reassessment Frequency

Standard protocols recommend reassessment every 1–2 hours during active withdrawal. Once scores fall below 8 on two consecutive evaluations, the interval may be extended to every 4–8 hours. Symptom-triggered protocols (STP) driven by serial CIWA-Ar scores consistently reduce total benzodiazepine exposure compared to fixed-schedule dosing, improving both safety and resource utilization.

Reference

Frequently asked questions

What CIWA-Ar score requires immediate medical treatment?
A CIWA-Ar score of 15 or higher indicates moderate-to-severe alcohol withdrawal and requires active pharmacological management, typically with benzodiazepines such as lorazepam or diazepam. Scores of 20 or above signal severe withdrawal with high risk of generalized tonic-clonic seizures or delirium tremens. Patients with prior withdrawal seizure history or severe dependence should receive pharmacotherapy at even lower threshold scores, as clinical history modifies risk independent of the numerical total.
How often should the CIWA-Ar assessment be repeated during alcohol withdrawal?
During active alcohol withdrawal, the CIWA-Ar should be repeated every 1 to 2 hours until scores stabilize below 8 to 10 on two consecutive assessments. Once stabilized, reassessment intervals may be extended to every 4 to 8 hours. Symptom-triggered protocols guided by serial CIWA-Ar scores have been shown in clinical studies to significantly reduce total benzodiazepine administered compared with fixed-schedule dosing regimens, lowering risks of oversedation and respiratory depression.
What medications are typically prescribed based on CIWA-Ar scores?
Benzodiazepines are the first-line pharmacotherapy for alcohol withdrawal syndrome. Common symptom-triggered protocols administer lorazepam 1 to 2 mg IV or IM, or diazepam 5 to 10 mg orally, when CIWA-Ar scores exceed 8 to 10. For scores above 15 to 20, higher or more frequent doses are required. Phenobarbital serves as a useful adjunct or alternative, particularly in benzodiazepine-refractory cases. Carbamazepine and gabapentin are options for mild-to-moderate outpatient withdrawal in patients with lower seizure risk.
Can the CIWA-Ar calculator predict alcohol withdrawal seizures?
The CIWA-Ar functions as a severity-staging tool rather than a direct seizure-risk predictor. Scores of 15 or above correlate with meaningfully elevated seizure and delirium tremens risk. However, withdrawal seizures can occur early — sometimes before the CIWA-Ar score reaches its peak — so additional risk factors must inform the overall assessment. These factors include prior withdrawal seizure history, quantity and duration of daily alcohol consumption, number of prior detoxifications, and concomitant use of other CNS depressants.
What is the difference between the CIWA-Ar and the original CIWA scale?
The original Clinical Institute Withdrawal Assessment (CIWA) contained 15 items. The revised version, CIWA-Ar, reduced this to 10 items by removing five subscales — including pulse rate and blood pressure — that contributed length but limited incremental clinical decision-making value, since vital signs are recorded separately. The CIWA-Ar achieves comparable psychometric reliability and validity in an administration time of approximately 5 minutes, making it substantially more practical for routine bedside use in emergency departments, inpatient units, and intensive care settings.
Who is qualified to administer the CIWA-Ar assessment?
The CIWA-Ar is designed for administration by trained healthcare professionals, including registered nurses, physicians, nurse practitioners, and physician assistants who have received structured instruction in alcohol withdrawal assessment methodology. Standardized training ensures consistent scoring across clinicians and care settings. The tool requires direct clinician observation of objective physical signs — including tremor, diaphoresis, and agitation — combined with structured patient questioning about perceptual disturbances and temporal orientation. It is not a self-administered patient questionnaire.